The nation of Zimbabwe has rejected a significant American health deal worth 367 million US dollars (£272m) over five years due to Washington's request for sensitive information.
This rejection became public following a government memo from December was disclosed, which showed President Emmerson Mnangagwa believed the agreement was "lopsided".
A government representative later clarified that the US was seeking biological samples for research and commercial purposes but refused to share the benefits from any future treatments.
"We will now turn to the challenging and unfortunate task of winding down our health assistance in Zimbabwe," stated American envoy to Zimbabwe Pamela Tremont in a statement.
The US Embassy indicated the US had provided more than $1.9bn as health assistance to Zimbabwe over the last twenty years.
A physicians' group in Zimbabwe has appealed for continued dialogue to secure a deal acceptable to both sides so the nation's vital HIV treatment initiative can proceed.
Wider Implications
Zimbabwe's decision comes after a similar case in Kenya, where a high court blocked a similar deal with the US after concerns were raised about the safety of citizens' health data.
Since resuming office last year, US President Donald Trump has slashed overseas assistance and shut down the US Agency for International Development (USAID).
USAID had managed assistance for the US government, but Trump stated its expenditure was "wasteful" and his government was pursuing government-to-government deals to boost transparency and accountability.
As per reports, 16 nations in Africa have to date agreed to similar agreements, constituting over $18.3bn of fresh investment.
Details of the Declined Deal
The funds for Zimbabwe would have gone towards "HIV/Aids treatment and prevention, TB, malaria, healthcare for mothers and children, and preparing for epidemics".
"We believe this collaboration might have yielded extraordinary benefits for Zimbabwean communities, especially the 1.2 million currently receiving HIV treatment through US-supported programmes," Tremont said.
However, government spokesperson Nick Mangwana maintained the arrangement was "unequal".
"Zimbabwe was being asked to share its genetic material and health information indefinitely, without any equivalent assurance of benefiting from any medical innovations – such as new medicines or tests – that could result from that provided information," he stated.
"In essence, our nation would provide the basic resources for medical research with no certainty that the resulting innovations would be accessible to our people should a future health crisis emerge."
Sovereignty and International Frameworks
He also said that the US's withdrawal from the World Health Organization (WHO) and its pursuit of bilateral health agreements were undermining frameworks already established through the global organization.
The spokesperson cited its Pathogen Access and Benefit Sharing scheme created to manage potential pandemics.
"This framework is intended to guarantee that when a country contributes its information, the resulting advantages – including vaccines and treatments – are shared equitably, not commercialised solely by those with the capability to develop them."
Zimbabwe's reservations over the US deal "should not be misconstrued as opposition to America," he added.
"We welcome further discussions with our American counterparts on how subsequent collaboration could be designed in a way that honours the sovereignty and interests of each country."
Health Experts Reaction
A leading public health body said it understood the official position, but suggested that talks should continue given that a large portion of the country's HIV programmes depended on external financing.
"If specific concerns arise, including those involving data governance or implementation frameworks, these can often be resolved through technical clarification and mutually agreed protections," it said.
The situation underscores the continuing challenges between accepting vital international aid and safeguarding national sovereignty in an increasingly interconnected world.